对辅助用药进行临床干预的效果分析

Effect Analysis of Clinical Intervention on Adjuvant Drugs

目的:探讨临床干预手段对医院辅助用药临床使用合理性的作用效果。方法:抽取2020年12月—2021年5月(临床干预前)医院辅助用药临床使用排名前10名的辅助用药共2819份病历作为对照组,抽取2021年6月—12月(临床干预后)临床使用排名前10名的辅助用药共2607份病历作为观察组。比较两组辅助用药使用数量、使用金额以及临床使用合理性。结果:观察组辅助用药使用金额比例占全院药品使用金额比例低于对照组,但差异无统计学意义(P>0.05);观察组排名前10名的辅助用药临床使用数量、金额、不合理情况均小于对照组(P<0.05)。结论:采用临床干预手段可以提高辅助用药合理化水平,降低患者的就医压力。

Objective:To explore the effect of clinical intervention on the rationality of clinical use of adjuvant drugs in hospitals.Methods:A total of 2819 medical records of the top 10 adjuvant drugs used in the hospital from December 2020 to May 2021(before clinical intervention)were selected as the control group,and a total of 2,607 medical records of the top 10 adjuvant drugs used in the hospital from June 2021 to December 2021(after clinical intervention)were selected as the observation group.The amount of adjuvant drugs used,the amount of adjuvant drugs used and the rationality of clinical use of the two groups of data were compared and analyzed.Results:The proportion of the amount of adjuvant drug use in the observation group was lower than that in the control group,but the difference was not statistically significant(P>0.05).The number,amount and unreasonable situation of the top 10 adjuvant drugs in the observation group were less than those in the control group(P<0.05).Conclusion:Clinical intervention can improve the rationalization level of adjuvant drugs and reduce the pressure of patients.